- Medicines and Healthcare products Regulatory Agency
- Part of:
- Medicines and medical devices: product-specific information and Patient safety
- 5 November 2014
A summary of the evidence on the benefits and risks of vaginal mesh implants.
PDF, 5.08MB, 149 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
MHRA has produced a summary report of the evidence on the benefits and risks of vaginal mesh implants as part of ongoing research and after the Chief Medical Officer, Professor Dame Sally Davies, requested it.
Any commercially sensitive information has been redacted.
From a regulatory perspective, the benefits of the use of vaginal mesh implants outweigh the risks. We consider there is currently no justification for taking any regulatory action to remove these devices from use in UK hospitals.
Published: 5 November 2014